Over the past decade, the role of immunoscintigraphy using radiolabelled monoclonal antibodies has been steadily growing in clinical oncology, and in particular, in radioimmunotherapy and radioimmunoguided surgery for the treatment of primary, recurrent, and metastatic colorectal, ovarian, gastric, and prostate cancer. Herein, the authors review the requirements for successful tumour radioimmunodetection and related procedures.
Radiolabelled monoclonal antibodies in clinical and surgical oncology: A review / L., B., D'Andrea, V., F., B., F., S., A., D., DE ANTONI, E.. - In: PANMINERVA MEDICA. - ISSN 0031-0808. - 39:1(1997), pp. 46-52.
Radiolabelled monoclonal antibodies in clinical and surgical oncology: A review
D'ANDREA, Vito;DE ANTONI, Enrico
1997
Abstract
Over the past decade, the role of immunoscintigraphy using radiolabelled monoclonal antibodies has been steadily growing in clinical oncology, and in particular, in radioimmunotherapy and radioimmunoguided surgery for the treatment of primary, recurrent, and metastatic colorectal, ovarian, gastric, and prostate cancer. Herein, the authors review the requirements for successful tumour radioimmunodetection and related procedures.File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
